insights – Clintex : Clinical Trials Intelligence

Clintex Reflection on Covid-19 Vaccine Development & Update on CTi Development

April 15, 2021

The ClinTex vision of “New Medicine: Faster, Cheaper, Smarter” has been proven possible with the current pace and quality of Covid-19 vaccine development.

Status of Covid-19 Vaccine Clinical Trials

February 8, 2021

With all the information circulating at the moment, it is difficult to keep track of the important developments in the fight against Covid.

Covid19 Clinical Trial Data Hacking

December 1, 2020

State-sponsored hackers from China, Russia, Iran and North Korea are currently engaged in concerted attempts to steal coronavirus vaccine secrets in what security experts describe as “an intellectual property war”.

CTi Token Listed on KuCoin Exchange

November 30, 2020

ClinTex is extremely proud to announce that the CTi token (CTI) is now available on KuCoin!

COVID-19 Clinical Data Explosion: The Need for Intelligence in Clinical Trials

September 15, 2020

The volume and speed of data generation during the COVID-19 pandemic is unprecedented. This mountain of data is growing daily.

Covid-19 and “virtual” Clinical Trials

August 24, 2020

The effect of the pandemic was alarmingly immediate on clinical trials. Many trials experienced delays or were put on pause as hospitals that serve as trial sites were overwhelmed with COVID-19 patients and were no longer available.

ClinTex announce details of their CTi Token Presale

August 17, 2020

ClinTex announce details of their CTi Token Presale, which will give participants access to the $350bn/year Clinical trials market with a 50% price discount until 25th September 2020.